REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Farmaciya (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Farmaciya Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

MUP Farmaciya is based in Russia, with the head office in Kirovsk. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on October 30, 2002. There was a net sales revenue increase of 38.38% reported in MUP Farmaciya’s latest financial highlights for 2022. There was a total growth of 125.79% in MUP Farmaciya’s total assets over the same period. The net profit margin of MUP Farmaciya decreased by 1.91% in 2022.

Headquarters
Lenina, 18
Kirovsk; Murmansk Oblast; Postal Code: 184250

Contact Details: Purchase the MUP Farmaciya report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Farmaciya report to view the information.
Registered Capital:
Purchase the MUP Farmaciya report to view the information.
Incorporation Date:
October 30, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Farmaciya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
38.38%
Total operating revenue
38.38%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-54.82%
Total assets
125.79%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-1.91%
Return on Equity (ROE)
N/A
Quick Ratio
0.37%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?